CD1D and steatosis: Our study established a model of NAFLD and metabolic derangements by steroid administration for eight weeks in which the steroid-mediated steatosis was CD1d-dependent while steroid-induced liver necrosis and inflammation, insulin resistance, and hyperlipidemia were CD1d-independent.